1. Home
  2. ENLV vs INGN Comparison

ENLV vs INGN Comparison

Compare ENLV & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.72

Market Cap

196.2M

Sector

Health Care

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.41

Market Cap

172.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENLV
INGN
Founded
2005
2001
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.2M
172.4M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
ENLV
INGN
Price
$0.72
$6.41
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$20.00
$11.25
AVG Volume (30 Days)
236.1K
341.9K
Earning Date
05-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.42
EPS
N/A
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
N/A
$8.03
Revenue Next Year
N/A
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.86
52 Week Low
$0.66
$5.34
52 Week High
$2.10
$9.13

Technical Indicators

Market Signals
Indicator
ENLV
INGN
Relative Strength Index (RSI) 35.04 42.70
Support Level $0.66 $5.97
Resistance Level $1.25 $6.93
Average True Range (ATR) 0.05 0.35
MACD 0.00 -0.08
Stochastic Oscillator 16.31 19.05

Price Performance

Historical Comparison
ENLV
INGN

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: